• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Dickkopf-3 甲基化作为肝硬化相关肝细胞癌的预后因素。

Methylation of Dickkopf-3 as a prognostic factor in cirrhosis-related hepatocellular carcinoma.

机构信息

Key Laboratory of Artificial Cells, Third Central Hospital, Tianjin 300170, China.

出版信息

World J Gastroenterol. 2010 Feb 14;16(6):755-63. doi: 10.3748/wjg.v16.i6.755.

DOI:10.3748/wjg.v16.i6.755
PMID:20135726
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2817066/
Abstract

AIM

To investigate the prevalence and time of Dickkopf (DKK) family methylation and its clinical significance in hepatocarcinogenesis.

METHODS

Methylation of DKK family genes was quantitatively analyzed in 115 liver tissue samples, including 50 pairs of primary hepatocellular carcinoma (HCC) and matched noncancerous cirrhotic tissue samples, as well as 15 liver cirrhosis biopsy samples.

RESULTS

The methylation level of DKK3 was significantly higher in HCC tissue samples than in matched noncancerous cirrhotic tissue samples (P < 0.0001) or in liver cirrhosis biopsy samples (P = 0.0139). Receiver operator characteristic curve analysis confirmed that the percent of methylated reference (PMR) values of DKK3 could effectively discriminate HCC tissue samples from noncancerous tissue samples (AUC = 0.8146) or liver cirrhosis biopsy samples (AUC = 0.7093). Kaplan-Meier survival curves revealed that the progression-free survival time of patients with a higher DKK3 methylation level (PMR > 1%) was significantly shorter than that of those with a lower DKK3 methylation level (PMR < or = 1%) (P = 0.0255). Multivariate Cox analysis indicated that methylated DKK3 was significantly and independently related with a shorter survival time (relative risk = 2.527, 95% CI: 1.063-6.008, P = 0.036) of HCC patients.

CONCLUSION

Methylation of DKK3 is an important event in early malignant transformation and HCC progression, and therefore might be a prognostic indicator for risk assessment of HCC.

摘要

目的

研究 Dickkopf(DKK)家族甲基化的流行率和时间及其在肝癌发生中的临床意义。

方法

定量分析了 115 例肝组织样本中的 DKK 家族基因甲基化情况,包括 50 对原发性肝细胞癌(HCC)和配对的非癌性肝硬化组织样本,以及 15 例肝硬化活检样本。

结果

HCC 组织样本中 DKK3 的甲基化水平明显高于配对的非癌性肝硬化组织样本(P < 0.0001)或肝硬化活检样本(P = 0.0139)。受试者工作特征曲线分析证实,DKK3 的甲基化参考百分比(PMR)值可以有效区分 HCC 组织样本与非癌组织样本(AUC = 0.8146)或肝硬化活检样本(AUC = 0.7093)。Kaplan-Meier 生存曲线显示,DKK3 甲基化水平较高(PMR > 1%)的患者无进展生存期明显短于 DKK3 甲基化水平较低(PMR < 或 = 1%)的患者(P = 0.0255)。多变量 Cox 分析表明,甲基化 DKK3 与 HCC 患者较短的生存时间显著相关(相对风险 = 2.527,95%CI:1.063-6.008,P = 0.036)。

结论

DKK3 甲基化是早期恶性转化和 HCC 进展的重要事件,因此可能是 HCC 风险评估的预后指标。

相似文献

1
Methylation of Dickkopf-3 as a prognostic factor in cirrhosis-related hepatocellular carcinoma.Dickkopf-3 甲基化作为肝硬化相关肝细胞癌的预后因素。
World J Gastroenterol. 2010 Feb 14;16(6):755-63. doi: 10.3748/wjg.v16.i6.755.
2
Overexpression of Dickkopf 3 in hepatoblastomas and hepatocellular carcinomas.Dickkopf 3在肝母细胞瘤和肝细胞癌中的过表达。
Virchows Arch. 2009 Jun;454(6):639-46. doi: 10.1007/s00428-009-0772-4. Epub 2009 May 13.
3
Methylation of S100A8 is a promising diagnosis and prognostic marker in hepatocellular carcinoma.S100A8的甲基化是肝细胞癌中一种很有前景的诊断和预后标志物。
Oncotarget. 2016 Aug 30;7(35):56798-56810. doi: 10.18632/oncotarget.10792.
4
Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.甲胎蛋白检测对肝硬化患者肝细胞癌监测有益。
Am J Gastroenterol. 2015 Jun;110(6):836-44; quiz 845. doi: 10.1038/ajg.2015.100. Epub 2015 Apr 14.
5
Identification of prognostic biomarker in predicting hepatocarcinogenesis from cirrhotic liver using protein and gene signatures.利用蛋白质和基因特征鉴定预测肝硬化发生肝癌的预后生物标志物。
Exp Mol Pathol. 2019 Dec;111:104319. doi: 10.1016/j.yexmp.2019.104319. Epub 2019 Oct 30.
6
Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer.Wnt抑制因子-1(WIF1)和Dickkopf-3(DKK3)启动子甲基化在人类乳腺癌中的预后相关性
BMC Cancer. 2009 Jul 1;9:217. doi: 10.1186/1471-2407-9-217.
7
Serum Dickkopf-1 as a Biomarker for the Diagnosis of Hepatocellular Carcinoma.血清Dickkopf-1作为肝细胞癌诊断的生物标志物
Yonsei Med J. 2015 Sep;56(5):1296-306. doi: 10.3349/ymj.2015.56.5.1296.
8
Promoter methylation and mRNA expression of DKK-3 and WIF-1 in hepatocellular carcinoma.DKK-3和WIF-1在肝细胞癌中的启动子甲基化及mRNA表达
World J Gastroenterol. 2009 Jun 7;15(21):2595-601. doi: 10.3748/wjg.15.2595.
9
Combination of DKK1 and AFP improves diagnostic accuracy of hepatocellular carcinoma compared with either marker alone.与单独使用任何一种标志物相比,DKK1和甲胎蛋白(AFP)联合使用可提高肝细胞癌的诊断准确性。
Turk J Gastroenterol. 2016 Jul;27(4):375-81. doi: 10.5152/tjg.2016.15523.
10
Des-gamma-carboxyprothrombin in patients with hepatocellular carcinoma and liver cirrhosis.γ-羧基凝血酶原在肝细胞癌和肝硬化患者中的应用。
J Dig Dis. 2011 Dec;12(6):481-8. doi: 10.1111/j.1751-2980.2011.00521.x.

引用本文的文献

1
Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy.Wnt/β-catenin 信号通路在肿瘤发生和癌症治疗中的作用。
J Hematol Oncol. 2024 Jun 18;17(1):46. doi: 10.1186/s13045-024-01563-4.
2
Dickkopf-3: An Update on a Potential Regulator of the Tumor Microenvironment.Dickkopf-3:肿瘤微环境潜在调节因子的最新进展
Cancers (Basel). 2022 Nov 25;14(23):5822. doi: 10.3390/cancers14235822.
3
Methylation of the DKK3 promoter is associated with poor prognosis in patients with cervical adenocarcinoma.DKK3启动子的甲基化与宫颈腺癌患者的不良预后相关。
Int J Clin Exp Pathol. 2018 Feb 1;11(2):788-794. eCollection 2018.
4
Significant association of promoter hypomethylation with colorectal cancer.启动子低甲基化与结直肠癌的显著关联。
Oncol Lett. 2019 Aug;18(2):1564-1570. doi: 10.3892/ol.2019.10432. Epub 2019 Jun 4.
5
Association of BAX hypermethylation with coronary heart disease is specific to individuals aged over 70.BAX基因高甲基化与冠心病的关联在70岁以上个体中具有特异性。
Medicine (Baltimore). 2019 Jan;98(4):e14130. doi: 10.1097/MD.0000000000014130.
6
TRAIL, Wnt, Sonic Hedgehog, TGFβ, and miRNA Signalings Are Potential Targets for Oral Cancer Therapy.肿瘤坏死因子相关凋亡诱导配体(TRAIL)、Wnt、音猬因子、转化生长因子β(TGFβ)和微小RNA(miRNA)信号通路是口腔癌治疗的潜在靶点。
Int J Mol Sci. 2017 Jul 14;18(7):1523. doi: 10.3390/ijms18071523.
7
BMP6 Regulates Proliferation and Apoptosis of Human Sertoli Cells Via Smad2/3 and Cyclin D1 Pathway and DACH1 and TFAP2A Activation.BMP6 通过 Smad2/3 和细胞周期蛋白 D1 通路以及 DACH1 和 TFAP2A 的激活调节人支持细胞的增殖和凋亡。
Sci Rep. 2017 Apr 7;7:45298. doi: 10.1038/srep45298.
8
A novel FOXO1-mediated dedifferentiation blocking role for DKK3 in adrenocortical carcinogenesis.DKK3在肾上腺皮质癌发生中通过FOXO1介导的新型去分化阻断作用
BMC Cancer. 2017 Mar 1;17(1):164. doi: 10.1186/s12885-017-3152-5.
9
Adenovirus vector carrying REIC/DKK-3 gene: neoadjuvant intraprostatic injection for high-risk localized prostate cancer undergoing radical prostatectomy.携带REIC/DKK-3基因的腺病毒载体:用于接受根治性前列腺切除术的高危局限性前列腺癌的新辅助前列腺内注射
Cancer Gene Ther. 2016 Nov;23(11):400-409. doi: 10.1038/cgt.2016.53. Epub 2016 Oct 21.
10
A review on the diagnosis and treatment of hepatocellular carcinoma with a focus on the role of Wnts and the dickkopf family of Wnt inhibitors.一篇关于肝细胞癌的诊断和治疗的综述,重点介绍 Wnts 和 Dickkopf 家族的 Wnt 抑制剂的作用。
J Hepatocell Carcinoma. 2014 Mar 6;1:1-7. doi: 10.2147/JHC.S44537. eCollection 2014.

本文引用的文献

1
Promoter methylation and mRNA expression of DKK-3 and WIF-1 in hepatocellular carcinoma.DKK-3和WIF-1在肝细胞癌中的启动子甲基化及mRNA表达
World J Gastroenterol. 2009 Jun 7;15(21):2595-601. doi: 10.3748/wjg.15.2595.
2
Aberrant DNA methylation profile of hepatocellular carcinoma and surgically resected margin.肝细胞癌及手术切除边缘的异常DNA甲基化谱
Cancer Sci. 2009 Jun;100(6):996-1004. doi: 10.1111/j.1349-7006.2009.01138.x. Epub 2009 Mar 25.
3
Analyzing real-time PCR data by the comparative C(T) method.通过比较Ct法分析实时荧光定量PCR数据。
Nat Protoc. 2008;3(6):1101-8. doi: 10.1038/nprot.2008.73.
4
Epigenetic silencing of the WNT antagonist DICKKOPF-1 in cervical cancer cell lines.WNT拮抗剂DKK1在宫颈癌细胞系中的表观遗传沉默
Gynecol Oncol. 2008 May;109(2):270-4. doi: 10.1016/j.ygyno.2008.01.034. Epub 2008 Apr 2.
5
Quantitative promoter methylation analysis of hepatocellular carcinoma, cirrhotic and normal liver.肝细胞癌、肝硬化和正常肝脏的启动子甲基化定量分析
Int J Cancer. 2008 Jun 15;122(12):2800-4. doi: 10.1002/ijc.23433.
6
Cancer statistics, 2008.2008年癌症统计数据。
CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96. doi: 10.3322/CA.2007.0010. Epub 2008 Feb 20.
7
Dickkopf-3 as a new potential marker for neoangiogenesis in colorectal cancer: expression in cancer tissue and adjacent non-cancerous tissue.Dickkopf-3作为结直肠癌新生血管生成的一种新的潜在标志物:在癌组织和相邻非癌组织中的表达
Dis Markers. 2008;24(2):101-9. doi: 10.1155/2008/160907.
8
Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma.衰老肝脏、慢性肝炎和肝细胞癌中多个肿瘤抑制基因的异常甲基化。
Hepatology. 2008 Mar;47(3):908-18. doi: 10.1002/hep.22110.
9
Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma.多基因甲基化作为多中心肝细胞癌的克隆标志物
Br J Cancer. 2007 Nov 5;97(9):1260-5. doi: 10.1038/sj.bjc.6604016. Epub 2007 Oct 30.
10
Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma.异常甲基化在人类肝细胞癌分子发病机制中的机制及预后意义
J Clin Invest. 2007 Sep;117(9):2713-22. doi: 10.1172/JCI31457.